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Abstract
Background: Quantitative molecular methods (QMMs) such as quantitative real-time polymerase chain reaction
(q-PCR), reverse-transcriptase PCR (qRT-PCR) and quantitative nucleic acid sequence-based amplification (QT-NASBA)
are increasingly used to estimate pathogen density in a variety of clinical and epidemiological contexts. These
methods are often classified as semi-quantitative, yet estimates of reliability or sensitivity are seldom reported. Here,
a statistical framework is developed for assessing the reliability (uncertainty) of pathogen densities estimated using
QMMs and the associated diagnostic sensitivity. The method is illustrated with quantification of Plasmodium
falciparum gametocytaemia by QT-NASBA.
Results: The reliability of pathogen (e.g. gametocyte) densities, and the accompanying diagnostic sensitivity,
estimated by two contrasting statistical calibration techniques, are compared; a traditional method and a mixed
model Bayesian approach. The latter accounts for statistical dependence of QMM assays run under identical
laboratory protocols and permits structural modelling of experimental measurements, allowing precision to vary
with pathogen density. Traditional calibration cannot account for inter-assay variability arising from imperfect QMMs
and generates estimates of pathogen density that have poor reliability, are variable among assays and inaccurately
reflect diagnostic sensitivity. The Bayesian mixed model approach assimilates information from replica QMM assays,
improving reliability and inter-assay homogeneity, providing an accurate appraisal of quantitative and diagnostic
performance.
Conclusions: Bayesian mixed model statistical calibration supersedes traditional techniques in the context of
QMM-derived estimates of pathogen density, offering the potential to improve substantially the depth and quality
of clinical and epidemiological inference for a wide variety of pathogens.
Background
The development of quantitative molecular methods
(QMMs) has allowed the detection and quantification of
pathogens at concentrations below the threshold of de-
tection by conventional diagnostic tools [1]. Molecular
tools such as quantitative real-time polymerase chain
reaction (q-PCR), reverse-transcriptase PCR (qRT-PCR)
and quantitative nucleic acid sequence-based amplification
(QT-NASBA) are routinely used to estimate the density of
a variety of pathogens, including human immunodefi-
ciency virus (HIV), influenza viruses and Plasmodium spe-
cies protozoa which cause malaria. Pathogen density
estimates are increasingly being used in epidemiological
assessments (for example, to determine viral [2,3] and bac-
terial [4] transmissibility), clinical management (such as
in HIV [5] and bacterial pneumonia [6]), and to assess
the effectiveness of control interventions [7,8]. Therefore,
it is critically important that the quantitative and diagnos-
tic performance of QMMs is accurately appraised and that
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point-estimates of pathogen density are accompanied by
robust estimates of reliability (uncertainty).
The principles underlying QMMs such as qPCR,
qRT-PCR and QT-NASBA are broadly the same. Nucleic
acid in a sample is amplified together with a fluorescent
probe and the time taken for the reaction to achieve a
certain degree of fluorescence—the experimental meas-
urement—is used to estimate the initial quantity of nucleic
acid. ‘Absolute’ quantification [9] uses calibration or
‘standard’ curves of test samples with concentrations
measured precisely enough to be considered known,
so-called calibrators. Typically, this is achieved by diluting
a sample of high concentration measured by the available
gold standard quantitative diagnostic to yield a ‘dynamic
range’ of calibrators typically in the order of 4 to 8 loga-
rithms, a procedure called serial dilution. The alternative
‘relative’ quantification uses an internal reference gene
and calculates the relative expression ratio [10]. Based on
the theory of nucleic acid amplification, the quantity of
nucleic acid in the amplification phase increases exponen-
tially and so plotting the experimental measurement
against the logarithm of the calibrators yields a linear rela-
tionship. The fitted regression line describing this relation-
ship is called a calibration or standard ‘curve’. Statistical
calibration [11] refers to the process of using a calibration
curve to estimate an unknown (logarithm of ) quantity
of interest (here pathogen density) from an experimental
measurement.
Quantitative molecular methods have been described
as either quantitative or semi-quantitative [12]. In reality,
their performance ranges from quantitative and highly
accurate, to predominantly qualitative indicators of pres-
ence or absence. A cascade of numerous potential sources
of uncertainty in laboratory protocol [13] mean that most
QMMs lie between these extremes, having intermediate
quantitative resolution [14,15]. Regardless of the source,
uncertainties manifest in calibration curves with non-
negligible (intra-assay) residual error in experimental mea-
surements, and potential inter-assay variability among
slopes and intercepts, even when undertaken using stan-
dardized protocols within the same laboratory [13]. These
errors are widely acknowledged, defined in the MIQE
guidelines (minimum information for publication of
quantitative real-time PCR experiments) as ‘repeatability’
(intra-assay variance) and ‘reproducibility’ (inter-assay
variance) respectively [16], and are broadly indicative
of the quantitative and diagnostic performance of the
QMM in question.
Despite this, there is a lack of statistical understanding
on how exactly such (intra- and inter-assay) errors trans-
late into the reliability of estimated pathogen densities
or nucleic acid copy numbers, and into the diagnostic
sensitivity (sometimes termed ‘clinical sensitivity’ to dis-
tinguish it from ‘analytical sensitivity’ which refers to the
minimum number of detectable nucleic acid copies [16])
of the QMM. Indeed, calibration techniques developed
in the statistical literature [11] have not been adequately
applied in the context of QMMs. By contrast, in applied
physical science disciplines, particularly in analytical
chemistry, where calibration is also widely used, meth-
odological protocols are more firmly embedded within
their statistical foundations [17].
In this paper, statistical calibration techniques are ap-
plied, as a case study, to 12 calibration curves derived
from 12 QT-NASBA assays (1 curve per assay), generated
from a single laboratory [18], and used routinely for esti-
mating the density of Plasmodium gametocytes present in
human blood (gametocytaemia). The QT-NASBA assay
uses time to positivity (TTP) in minutes as an indirect
measure of pathogen density; the shorter the TTP, the
higher the density. Gametocytaemia density determines
host infectivity to mosquito vectors and has major epi-
demiological implications, ranging from quantifying the
contribution of different individuals to the reservoir of in-
fection [19], to assessing the effectiveness of transmission-
blocking interventions against malaria. Notwithstanding
the importance of QT-NASBA to malariologists, the
analytical approaches presented here are more broadly
applicable to the absolute quantification of a wide range
of pathogens by other QMMs. In particular, it is shown
how refinements to the traditional calibration approach
using random effects and implemented in a Bayesian
framework, enable data (calibration curves) from multiple
assays to be combined, yielding substantial improvements
in accuracy, reliability and consistency of statistical infer-
ence on estimated pathogen densities as well as in diag-
nostic sensitivity.
Methods
Ethical clearance
Data were primarily derived from cultured NF54 game-
tocytes; natural gametocyte isolates were used from a
previously published clinical study that received approval
from the Ministry of Health of Burkina Faso (2000/3174/
MS/SG/DEP).
The QT-NASBA technique
Full details on the molecular aspects of the QT-NASBA
technique are described elsewhere [18]. Briefly, 50-100 μl
of blood is collected; the RNA of gametocytes is extracted
and then amplified in the presence of a fluorescence
probe. The assay measures time to positivity (TTP) in
minutes which is the time it takes for the number of target
amplicons detected to exceed a defined threshold. In the
context of qPCR, TTP is analogous to the quantification
cycle (Cq), threshold cycle (CT), crossing point (CP), and
take-off point (TOP) [16].
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Assays
A QT-NASBA assay is typically run on a 48-well plate.
Here, 39 wells contained test samples of unknown gameto-
cyte density; 3 were reserved for negative controls (water),
and 6 wells contained samples of known gametocyte
density (calibrators) used to calibrate the TTP-gametocyte
density relationship. Experimental data from 12 QT-NASBA
assays are analysed in this paper to motivate and illustrate
the proposed analytical framework.
Calibrators
Calibrators were prepared using synchronized, purified
mature gametocytes derived from an in vitro culture of
P. falciparum [20]. A starting density of 106 gametocytes
per ml was estimated using microscopy and used in 6
tenfold dilution series (106 to 101 gametocytes per ml).
Hence, 6 calibrators were included in each of the 12
QT-NASBA assays.
Calibration curves
The log10 (base 10)-transformed density of calibrator
i = 1,2,…,n (here n = 6, i.e. 6 calibrators per assay)
from assay j = 1,2,…,r (here r = 12, i.e. 12 assays in total),
is denoted xij. The TTP value associated with each calibra-
tor (viz. each xij) is estimated using QT-NASBA and
denoted by the random variable Yij. The relationship
between TTP and pathogen density is described by a
linear mixed model (LMM) [21,22] of the form
Y ij ¼ β0j þ β1j  xij − x
 þ εij; ð1Þ
where x is the mean of the calibrators, εij is a normally
distributed residual error term with mean 0, and β0j and
β1j are random effects which follow a multivariate normal
distribution with a mean vector of fixed effects β = (β0, β1),
standard deviation (SD) vector τ = (τ0, τ1) and correlation
ρ. Setting τ = (0, 0), the LMM becomes a linear model
(LM) with fixed effects β0j = β0 and β1j = β1 (no random
variation among assay-specific regression coefficients).
Homoscedastic (constant) intra-assay residual variance is
defined by var(εij) = σ
2. Alternatively, heteroscedasticity
(non-constant intra-assay variance) is captured by defining
var(εij) as a non-constant function. Specifically, and based
on inspecting residuals of a fitted model (Figure 1), var
(εij) is defined as a log-linear function of the mean of
Y ij; μij ¼ β0j þ β1j  xij − x
 
;
var εij
  ¼ σ2exp γμij ; ð2Þ
noting that γ = 0 reproduces intra-assay homoscedasticity.
Classical calibration
Statistical calibration [11] concerns making inference on
an unknown value of the independent variable (gametocyte
density in assay j), denoted X0j, from a single experimental
observation (a TTP), y0j, or more generally from the mean
of m observations (TTPs), y0j ¼ Σiy0ij=m. Solving (1) for xij
and substituting xij and Yij for X0j and y0j respectively yields
X0j ¼ x þ y0j − β0j − εij
 
=β1j: ð3Þ
A point-estimate of X0j, denoted x^0j; is given by replacing
β0j and β1j in (3) with their so-called empirical best linear
unbiased predictors (EBLUPs) [21], denoted b0j and b1j,
x^0j ¼ x þ y0j − b0j
 
=b1j: ð4Þ
For the fixed effects LM where τ = (0,0), b0j = b0 and
b1j = b1, (4) becomes Eisenhart’s classical calibration
Figure 1 Heteroscedasticity of calibration or standard curves from quantitative nucleic acid sequence-based amplification (QT-NASBA)
assays. Panel A depicts the conditional raw residuals of a homoscedastic linear mixed model with a correlated random intercept and slope (the
homoscedastic homologue of the selected Model 7 in Table 2) plotted against the fitted time to positivity (TTP). The data points in panel B
depict the natural logarithm (ln) of the variance of the residuals presented in panel A grouped by deciles (10-quantiles) of fitted TTP. The solid
line and shaded area are for presentation purposes only, representing a linear regression ± 2 standard deviations respectively.
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estimator and the estimates b0 and b1 can be obtained
by ordinary least squares.
The classical calibration estimator [23], derived from a
linear regression model with normally distributed errors,
is the fixed effects version of (4),
x^0 ¼ x þ y0 − b0ð Þ=b1: ð5Þ
Uncertainty in the estimates b0 and b1 propagates into
the sampling distribution of x^0 resulting in a ratio distri-
bution with undefined moments [24,25]. Specifically, if
the residual error variance σ2 of the calibration curve is
known, x^0 is distributed as the ratio of two normally distrib-
uted random variables. More commonly, σ2 is estimated as
s2, and x^0 is distributed as the ratio of t distributed random
variables [26]. In practice, the distributional nuances of x^0
are seldom relevant for ‘high quality’ calibration curves where
the absolute magnitude of β1 is large relative to σ
2
, and there
are numerous and adequately dispersed calibrators (i.e. when
Σi xi−xð Þ2 is large). In such circumstances, b1 is strongly sig-
nificantly different from 0. Indeed, conditioning on this event
has proved a popular approach to ensure the existence of fi-
nite moments of x^0 [27,28]. By this method, the approximate
variance of x^0 is
var x^0ð Þ≃ σ
2
β21
1
n
þ 1
m
þ y0 − β0
 2
β21
X
i
xi − xð Þ2
þ 3σ
2
mβ21
X
i
xi − xð Þ2
 !
;
ð6Þ
which is used widely, particularly in analytical chemistry,
to construct confidence intervals (CIs); usually invoking
a t-distribution, replacing, respectively, σ2 and β1 with
s2 and b1, and assuming that the final term in the par-
entheses is negligible [17,29,30]. The so-called ‘fiducial’
CI [31] is also popular, derived by finding values of x^0
that satisfy the bounds of the prediction interval of y0
at x^0 [32],
x^0;L; x^0;U
  ¼ x þ y0 − b0
b1 1 − gð Þ
 t
b1 1 − gð Þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 − gð Þs2 1
m
þ 1
n
	 

þ s
2 y0 − b0ð Þ2
b1
X
i
xi − xð Þ2
vuut ;
ð7Þ
where
g ¼ t2s2= b21
X
i
xi − xð Þ2
 
; ð8Þ
and t is the critical value of Student’s t-distribution with
n +m −3 degrees of freedom. Term g (the ‘g statistic’) is
important because it inversely measures the ‘performance’ of
a calibration curve, assimilating the gradient, the residual
variability, and the number and spread of the calibrators
into a single metric; as g→ 0 the variance of x^0 decreases
[33-35]. It is also noteworthy that as g→ 0, the fiducial CI
tends to the CI constructed using the variance approxima-
tion. Indeed, the later approach is deemed valid only for
g < 0.05 [17]. The fiducial limit, although generally more
versatile than the variance approximation approach,
performs increasingly poorly for increasing g [26,36].
Bayesian calibration
In general, the undefined moments of the ratio distribu-
tion b0j / b1j create problems for the quantification of SE
by traditional (frequentist) approaches, albeit point esti-
mates are largely invariant. This is particularly the case
for a LMM where prerequisite estimation of uncertainty
in the EBLUPs (b0j and b1j) is problematic [21]. The
Bayesian solution [11] rests on evaluating the posterior
distribution of X0j, given by Bayes’ theorem,
p X0j y0j; θÞ∝p y0j X0j; θ
 p X0jjθÞ; ð9Þ
where θ represents in a generic manner the parameters
of the hetero- or homoscedastic LM or LMM. Indicated
by (9) is that—in the absence of observed y0j—the
posterior distribution (hereafter abbreviated to posterior)
of X0j can be simulated via the posterior predictive dis-
tribution [37] of Y at X0j ¼ x0j; pðy0j X0j ¼ x0j; θÞ
 , be-
fore applying the rearranged regression (3). Therefore,
p(X0j|ӯ0j,θ) is rewritten as p(X0j|x0j,θ). Simulating from
p(X0j|x0j,θ) in this way enables the performance of cali-
bration curves (summarized in terms of reliability and
diagnostic sensitivity) to be evaluated at chosen hypothet-
ical values of the ‘true’ unknown gametocyte density. In
general, it is necessary to evaluate p(X0j|x0j,θ) numerically
by Markov chain Monte Carlo (MCMC) methods.
Simulations were conducted by MCMC sampling
implemented in OpenBUGS (http://www.openbugs.net)
[38], the currently maintained and updated version of
WinBUGS [39]. To reflect the absence of prior informa-
tion on the parameter values, vague (uninformative) prior
distributions were defined for the θ: regression coefficients
[fixed effects, including those of the log-linear heterosce-
dastic function defined by (2)] and random effects were
assigned normal priors with mean 0 and variance 1000;
variance parameters were assigned inverse-gamma priors
with shape and rate parameters equal to 0.001, and the co-
variance matrix Σ of linear mixed models was assigned an
inverse Wishart distribution with 2 degrees of freedom
[37]. Three Markov chains were initialized for each simu-
lation. Visual inspection of the Markov chains, autocorrel-
ation plots and the Gelman-Rubin statistic [37] were used
to assess convergence on the parameter posterior distribu-
tions and to check that the conclusions were not sensitive
to the choice of starting values. In general, the first 2,500
samples from each chain were discarded as ‘burn-in’ and a
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further 50,000 samples were used to estimate the marginal
posterior distributions.
Results
Goodness of fit
Calibration curves fitted to the Plasmodium gametocytaemia
data from the 12 assays, either individually using a homosce-
dastic (constant intra-assay variance) linear model (HoLM)—
also referred to as the traditional approach—or collectively
using a heteroscedastic (dynamic intra-assay variance) lin-
ear mixed model (HeLMM), are depicted in Figure 2. Par-
ameter estimates and summary statistics of the HoLMs
are given in Table 1. The goodness-of-fit of these models
varies considerably among assays, from R2 = 97% in assay
7 (assay j = 7) to R2 = 74% in assay 4 (assay j = 4). Reflecting
this heterogeneity, the 95% prediction intervals for the mean
ofm TTP observations, y0j; from hypothetical ‘true’ values of
log10 gametocyte density, x0j, also vary markedly (Figure 2).
The HeLMM was selected from several parameteriza-
tions of the LMM (including homoscedastic variants)
which were compared using the deviance information
criterion (DIC) [40] (Table 2). The selected LMM with
the lowest DIC included a correlated random intercept
and slope, and intra-assay heteroscedastic errors (Model
7 in Table 2). Inclusion of heteroscedasticity yielded par-
ticularly large reductions in the DIC of all models com-
pared with their homoscedastic counterparts (Table 2),
consistent with an analysis of the residuals from the
homoscedastic LMM (Figure 1). Generally, the fitted
lines (strictly, posterior means) of the selected HeLMM
do not differ substantially from the individually-fitted
HoLMs. Posterior means and SDs of estimated parameters
of all LMM parameterizations are given in Table 3.
Performance and variability
The performance of calibration curves is summarized in
terms of reliability and diagnostic sensitivity. Specifically,
inference is based on the numerical (MCMC) approxi-
mation of the gametocyte density posterior conditioned
on known x0j and parameters θ, p(X0j|x0j,θ). Reliability is
measured by either the 95% Bayesian credible interval
(BCI) (Figure 3) or the SD (hereafter referred to in a
frequentist manner as a standard error, SE) (Figure 4)
of p(X0j|x0j,θ). Diagnostic sensitivity is quantified by
the percentage of realizations from p(X0j|x0j,θ) greater
than 1 gametocyte per 0.05 ml volume of test sample
(the volume in a single well of a plate used to run each
assay) (Figure 3).
Figure 2 Calibration or standard curves derived from individual quantitative nucleic acid sequence-based amplification (QT-NASBA)
assays. Panels depict data and fitted calibration curves for assays j = 1,2,…,12. Solid and broken lines denote medians and 95% Bayesian credible
intervals (BCIs) of the posterior predictive distribution of time to positivity (TTP) calculated from the heteroscedastic linear mixed model (HeLMM)
and the homoscedastic linear model (HoLM) respectively (note that for the HoLM these are identical to classical frequentist prediction intervals).
Dark and light grey lines correspond to, respectively, BCIs for m = 1 TTP observation and the mean of m = 3 TTP observations.
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Estimates of reliability (Figure 3; Figure 4) and sensi-
tivity (Figure 5) derived from HoLMs are highly hetero-
geneous, reflecting substantial variation in performance
among calibration curves (assays). This heterogeneity is
also captured by the so-called g statistic (8) (Table 1)
which expresses the performance of each HoLM in a
single metric. The g statistic also indicates when uncer-
tainty intervals constructed using classical frequentist
approximations [e.g. Equation (7)] will prove satisfactory
(Additional file 1). By contrast, calibration using the se-
lected HeLMM (Model 7, Table 2) yields less variable es-
timates of reliability (Figure 3; Figure 4) and sensitivity
(Figure 5) by the (random effects) assumption that data
from different assays are statistically related; that is,
calibration curves are realizations from an underlying dis-
tribution, each with a different intercept and slope (Table 2),
but with the same (heteroscedastic) intra-assay variance
function (2).
Intra-assay heteroscedasticity decreases the SE of the
gametocyte density (decreases variance, Figure 1) with
increasing x0j in a density-dependent manner (Figure 3;
Figure 4). Consequently, the reliability of the HeLMM-
derived estimates at low x0j, while quite homogeneous
among assays, is only moderately superior to the major-
ity of HoLM-derived estimates. Conversely, at high x0j,
HeLMM-derived estimates are markedly more reliable
(Figure 3, Figure 4). Heteroscedasticity also introduces
density dependence into diagnostic sensitivity, reducing
the sensitivity estimated from the HeLMM compared to
the HoLM at low x0j, and vice versa. Indeed, at 10 gameto-
cytes per ml, the HeLMM-derived estimates of sensitivity
are between 25% and 50% compared to the HoLM-
derived estimates which are all greater than 75% (Figure 4).
Unsurprisingly, the SE and sensitivity estimated by both
models over the range of x0j is improved by increasing m
replica TTP observations (Figure 5).
Discussion
The availability of QMMs has led to a new dimension in
clinical and epidemiological research, in which pathogen
densities can be detected and quantified below the
thresholds of conventional diagnostics. Despite broad
awareness of the numerous potential sources of uncer-
tainty inherent to QMMs, even implemented using stan-
dardized experimental protocols, there has hitherto been
a lack of clear explanation on how these uncertainties:
(a) manifest as intra- and inter-assay errors in calibration
curves; (b) project onto the reliability (uncertainty) of es-
timated pathogen densities and the diagnostic sensitivity
of the QMM, and (c) should be handled statistically to
estimate robust measures of quantitative and diagnostic
performance. These gaps perhaps explain why estimates
of reliability and sensitivity—essential metrics for statistical
inference—seldom accompany point pathogen density esti-
mates. The presented analysis serves to address these issues
by calling attention to calibration methods developed in
the statistical literature and refining these techniques to
develop a novel and powerful modelling framework.
Calibration curves, reliability and sensitivity
Previous studies on the reliability of QMM-derived esti-
mates have focused predominantly on uncertainty and
intra-assay variability in nucleic acid amplification effi-
ciency [41-43], rather than uncertainty in measures of esti-
mated nucleic acid concentrations or pathogen densities.
This is understandable given the uppermost importance
of a consistent amplification efficacy for analytical ap-
proaches designed for relative quantification [10] and
Table 2 Summary of the linear mixed models fitted by
Bayesian Markov chain Monte Carlo methods
Model Random
effects
Correlated random
effects
Heteroscedasticity DICa
1 Slope NAb ✗ 302
2 Intercept NA ✗ 250
3 Intercept;
slope
✗ ✗ 248
4 Intercept;
slope
✓ ✗ 243
5 Intercept NA ✓ 196
6 Intercept;
slope
✗ ✓ 189
7 Intercept;
slope
✓ ✓ 183
Symbols: ✓, included in the model; ✗ not included in the model.
aDeviance information criterion.
bNot applicable.
Table 1 Summary of the homoscedastic linear model
calibration curves fitted by ordinary least squares
Curve Intercepta, β0 (SE
b) Slope, β1 (SE) Variance, σ
2 R2 gc
j = 1 30.87 (0.96) −4.42 (0.56) 5.58 0.94 0.13
j = 2 32.46 (1.90) −4.79 (1.11) 21.75 0.82 0.42
j = 3 30.88 (0.64) −3.80 (0.38) 2.47 0.96 0.08
j = 4 30.82 (2.35) −4.59 (1.37) 33.00 0.74 0.69
j = 5 27.00 (0.51) −2.48 (0.30) 1.54 0.95 0.11
j = 6 33.89 (1.16) −2.69 (0.68) 8.14 0.79 0.50
j = 7 31.21 (0.53) −3.49 (0.31) 1.66 0.97 0.06
j = 8 24.09 (0.46) −2.40 (0.27) 1.25 0.95 0.09
j = 9 24.28 (0.91) −2.98 (0.53) 4.93 0.89 0.24
j = 10 30.25 (1.62) −4.73 (0.95) 15.78 0.86 0.31
j = 11 27.71 (0.58) −3.15 (0.34) 2.00 0.96 0.09
j = 12 20.85 (0.58) −2.51 (0.34) 2.00 0.93 0.14
aCalibrators, xij, were centered about their mean, x ; ensuring that ‘intercept’
terms correspond to the respective estimates at xij ¼ x .
bStandard error.
cCalculated using a Student’s critical t value at a significance level of 5% and
n +m −3 = 4 + 1–3 degrees of freedom (8).
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because, for microparasitic pathogens (viruses, bacteria,
protozoa), relative quantification, or just detection (presence
or absence), is often considered sufficient in clinical con-
texts [42]. However, in terms of absolute quantification,
variation in amplification efficiency—which manifests as
inter-assay variability among the slopes of calibration
curves—does not determine the reliability of estimates
per se. This assertion is embodied by the g statistic, a
single-metric indicator of the ‘performance’ of a simple
linear calibration curve (a HoLM) which influences in a
Table 3 Parameter estimates from the linear mixed models fitted by Bayesian Markov chain Monte Carlo methods
Model Fixed effects Random effects Log-linear variance
Intercept, β0 (SD
a) Slope, β1 (SD) Covariance matrix, Σ (SD) exp(intercept), σ
2 (SD) Slope, γ (SD)
1 28.7 (0.6) −3.5 (0.4)
0 0
0 0:1 0:3ð Þ
 
23.3 (4.1) 0
2 28.7 (1.2) −3.5 (0.2)
16:8 9:9ð Þ 0
0 0
 
10 (1.9) 0
3 28.7 (1.3) −3.5 (0.3)
17:1 10:1ð Þ 0
0 0:3 0:4ð Þ
 
9.3 (1.9) 0
4 28.7 (1.2) −3.5 (0.3)
14:6 8:0ð Þ −2:5 1:6ð Þ
−2:5 1:6ð Þ 0:5 0:4ð Þ
 
9.0 (1.7) 0
5 28.1 (1.0) −3.0 (0.2)
12:1 6:8ð Þ 0
0 0
 
0.0 (0.0) 0.2 (0.0)
6 28.2 (1.1) −3.1 (0.2)
14:0 8:0ð Þ 0
0 0:2 0:2ð Þ
 
0.0 (0.0) 0.2 (0.0)
7 28.4 (1.1) −3.3 (0.2)
14:2 8:3ð Þ −1:4 1:3ð Þ
−1:4 1:3ð Þ 0:2 0:2ð Þ
 
0.0 (0.0) 0.2 (0.0)
aStandard deviation.
Figure 3 Reliability of Plasmodium falciparum gametocyte densities estimated by individual quantitative nucleic acid sequence-based
amplification (QT-NASBA). Panels depict hypothetical ‘true’ and estimated gametocyte densities for assays j = 1, 2,…, 12. Solid and broken lines
denote, respectively, medians and 95% Bayesian credible intervals (BCIs) of the gametocytaemia posterior distributions calculated from the
heteroscedastic linear mixed model (HeLMM) and the homoscedastic linear model (HoLM), as defined in the main text. Dark and light grey lines
correspond to, respectively, BCIs for m = 1 time to positivity (TTP) observation and the mean of m = 3 TTP observations. The light-grey shaded
area indicates the detection threshold of 1 gametocyte per 0.05 ml of blood.
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non-linear manner the reliability of derived estimates and
includes all the components of a desirable, ‘high performing’
calibration curve; one with a steep slope, numerous cali-
brators spread over a wide dynamic range, and a small
degree of residual variability of experimental measurements.
The diagnostic sensitivity of a QMM is inextricably as-
sociated with the reliability of estimated pathogen dens-
ities. That is, purely by chance, the number of pathogens
in a positive sample may be estimated, via a calibration
curve, as less than 1. The probability of this occurrence
Figure 4 Variability of Plasmodium falciparum gametocyte density reliability estimates from quantitative nucleic acid sequence-based
amplification (QT-NASBA). The boxes surrounded by dashed lines and solid lines depict, respectively, the distribution of assay-specific gametocyte
density posterior standard deviations (analogous to, and labelled as, frequentist standard errors, SEs) derived from the 12 individually-fitted
homoscedastic linear models (HoLMs) and the heteroscedastic linear mixed model (HeLMM). Boxes span from the 25th to the 75th percentiles
(the interquartile range) of the estimated SEs and whiskers a further 1.5 × the interquartile range. Points outside of this range are indicated
and horizontal bars (broken and solid) denote the medians. Boxes shaded dark grey and light grey correspond to, respectively, estimates
derived from a single time to positivity (TTP) observation (m = 1) or the mean of 3 TTP observations (m = 3).
Figure 5 Sensitivity and consistency of detecting Plasmodium falciparum gametocytes by quantitative nucleic acid sequence-based
amplification (QT-NASBA). The boxes surrounded by dashed lines depict, respectively, the distribution of assay-specific sensitivities derived from
the 12 individually-fitted homoscedastic liner models (HoLMs) and the heteroscedastic linear mixed model (HeLMM). Boxes span from the 25th to
the 75th percentiles (the interquartile range) of the estimated sensitivities and whiskers a further 1.5 × the interquartile range. Points outside of this
range are indicated and horizontal bars (broken and solid) indicate medians. Boxes shaded dark grey and light grey correspond to, respectively,
estimates derived from a single time to positivity (TTP) observation (m = 1) or the mean of 3 TTP observations (m = 3).
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defines diagnostic sensitivity. The results presented here
indicate that the uncertainty in QT-NASBA point-
estimates increases with decreasing gametocyte densities
in a density-dependent manner. The compounding of
(initially small) errors throughout the dilution series is
a likely and possibly predominant reason for this; at
each dilution, additional uncertainty is introduced in the
number of ‘known’ gametocytes, error which propagates
into the variability of the experimental measurements
(TTPs). The net result is that the diagnostic sensitivity
of the assay is also density-dependent, decreasing with
decreasing gametocyte density (Figure 4). This finding is
consistent with other QMMs used to quantify the dens-
ity of a variety of pathogens [44-46], indicating a general
result. It is thus important to emphasize that failing to
capture accurately, using a statistical model, systematic
changes in the residual variation of experimental measures
about a calibration line (intra-assay variance) (Figure 1)
risks inaccurately estimating reliability (Figure 4) and diag-
nostic sensitivity (Figure 5).
Statistical dependence of calibration curves
Heterogeneity in the quality of calibration curves derived
from different QMM assays is inescapable; consequently,
variation in estimates of reliability and sensitivity (collect-
ively referred to as ‘performance’) is also inevitable. This is
the case in state-of-the-art laboratories using rigorous and
standardized experimental protocols [13], and even more
so in difficult field settings [47]. Refinements to experi-
mental protocols, including statistically-driven efforts to
optimize the number and distribution of calibrators [34],
will reduce but not eliminate variation in the quality of
calibration curves. Furthermore, the impact of quality
on performance is intensified by the practice of using
relatively few calibrators per assay (here 6 calibrators
were used per 48-well plate, 6 to 8 being commonplace).
The ‘traditional’ calibration approach, whereby calibra-
tion curves from different assays are treated as statistically
independent, yields considerable variation in estimates of
performance. This is compounded with the ubiquitous
assumption of homoscedasticity (constant intra-assay
variance) of experimental measures—despite observations
that SEs tend to be greater at low nucleic acid concen-
trations or densities (density dependence) of a variety of
pathogens [41,44,48]—resulting in performance estimates
that are inaccurate as well as heterogeneous. This presents
particular difficulties to studies concerned with inference
at low pathogen densities [19,49], not only because this is
where the problem is worst, but also because this is pre-
cisely where QMMs are preferred for their superior detec-
tion sensitivity compared with conventional diagnostics.
The problem of variable performance estimates is re-
solved using mixed model techniques [21,22] adapted to
statistical calibration [50]. Mixed models treat calibration
curves from different assays as statically related, permit-
ting inference on simultaneous analysis of all data derived
from a set of assays run at a particular time or in a par-
ticular laboratory. (In principle, the effect of laboratory,
time and any other measurable covariate could be incor-
porated into the framework presented here, although this
is beyond the scope of the current paper.) The problem of
inaccurate performance estimates is resolved by departing
from the assumption of constant intra-assay variability
and explicitly modelling density dependence in the re-
sidual variance of experimental measures about calibration
curves (Figure 1), a construct that can be embedded
within the mixed model framework. The resulting het-
eroscesdastic mixed model comes, of course, with the
requirement to justify the modelling assumptions and is
more technically challenging and time consuming to
implement than a traditional calibration approach, which
is based on the simple linear regression model. Nevertheless,
the Bayesian MCMC techniques that provide the versatil-
ity to implement almost arbitrarily complex custom-built
mixed models are now readily accessible in statistical soft-
ware packages such as WinBUGS [39], OpenBUGS [38],
and JAGS [51]. In the end the decision about whether or
not to conduct the more time consuming Bayesian ana-
lysis will depend on the g statistic (a value which should
always be quoted) and the degree of precision required
from the assay.
The hazards of ‘quality control’
Hitherto, the issue of variable quality calibration curves
and the resulting heterogeneous assay performance has
been addressed under the broad banner of ‘quality control’.
Strategies have included post hoc exclusion of ‘outlying’
calibration data points [41,44] and vetting of calibration
curves, as practiced for quantification of hepatitis B and
Epstein-Barr viraemias [34]. Both approaches are statisti-
cally equivocal unless there are measured independent
variables (covariates) to explain the ‘unexpected’ data. For
example, exclusion of the poorest quality calibration curve
from assay 4 (see Figure 2 and Table 1) would have: (a)
made valid statistical inference on the value of an un-
known gametocyte density run on that particular assay ex-
tremely difficult, but more importantly (b) rendered the
estimated performance of all other assays—which are in-
formed by the quality of all the calibration curves—overly
optimistic. In essence, the calibration data from assay 4
were observed without a priori information to explain
their somewhat ‘unexpected’ or ‘outlying’ nature and so
they should contribute information to the estimated per-
formance of replica assays like any other. Myriad explana-
tory variables such as time, reagent batch, technician etc.
could be legitimately included in the analysis and may
demonstrate that quality, and hence performance, is genu-
inely better or worse under particular circumstances.
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Conclusions
Taking the quantification of gametocytaemia by QT-NASBA
in P. falciparum infections as an example, this paper il-
lustrates that: (a) the reliability of estimated pathogen
densities, and the diagnostic sensitivity of a QMM, which
together define performance, depend on properties of
assay-specific calibration curves, namely the slope, the
number and spread of calibrators, and the residual
variability of experimental measurements; (b) perform-
ance is density-dependent if intra-assay residual vari-
ability is dynamic over the range of the calibrators, and
if density dependence is ignored, estimates of perform-
ance will be inaccurate; (c) random variation in the
quality of calibration curves from different QMM as-
says produces variable performance estimates, hamper-
ing robust statistical inference; (d) the relatedness of
calibration curves derived from replica assays can be
exploited, using mixed models, to improve the reliabil-
ity and consistency of results. Together, these insights
demonstrate that investing in appropriate and powerful
statistical techniques, ideally as part of routine analysis,
can greatly facilitate the interpretation of molecularly-
derived estimates of pathogen density, ultimately improving
inference in a wide range of clinical and epidemiological
contexts.
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